Vitronectin's Basic Domain is a Syndecan Ligand which Functions in transto Regulate Vitronectin Turnover

REFERENCES

• Aaboe M, Offersen BV, Christensen A, Andreasen PA (2003). Vitronectin in human breast carcinomas. Biochim Biophys Acta 1638: 72–82.
   PubMed Web of Science ®Google Scholar
• Adams JC, KureishyN, TaylorAL(2001).Arole for Syndecan-1 in coupling fascin spike formation by thrombospondin-1. J Cell Biol 152: 1169–1182.
   Google Scholar
• Baeuerle PA, Huttner WB (1986). Chlorate-A potent inhibitor of protein sulfation in intact cells. Biochem Biophys Res Comm 141: 870–877.
   PubMed Web of Science ®Google Scholar
• Bernfield M, Gotte M, Park P, Reizes O, Fitzgerald M (1999). Functions of cell surface heparan sulfate proteoglycans. Ann Rev Biochem 68: 729–778.
   PubMed Web of Science ®Google Scholar
• Cardin AD, Weintraub HJR (1989). Molecular modeling of protein-glycosaminoglycan interactions. Atherosclerosis 9: 21–31.
   Google Scholar
• Carreiras F, Cruet S, Staedel C, Sichel F, Gauduchon P (1999). Human ovarian adenocarcinoma cells synthesize vitronectin and use it to organize their adhesion. Gynecol Oncol 72: 312–322.
   PubMed Web of Science ®Google Scholar
• Carreiras F, Denoux Y, Staedel C, Lehmann M, Sichel F, Gauduchon P (1996). Expression and localization of ?v integrins and their ligand vitronectin in normal ovarian epithelium and in ovarian carcinoma. Gynecol Oncol 62: 260–267.
   PubMed Web of Science ®Google Scholar
• Chain D, Korc-Grodzicki B, Kreizman T, Shaltiel S (1991). Endogenous cleavage of the Arg-379-Ala-380 bond in vitronectin results in a distinct conformational change which ‘buries’ Ser- 378, its site of phosphorylation by protein kinase A. Biochem J 274: 387–394.
   PubMed Web of Science ®Google Scholar
• Cherny RC, Honan MA, Thiagarajan P (1993). Site-directed mutagenesis of the arginine-glycine-aspartic acid in vitronectin abolishes cell adhesion. J Biol Chem 268: 9725–9729.
   PubMed Web of Science ®Google Scholar
• Couchman JR, Chen L, Woods A (2001). Syndecans and cell adhesion. Int Rev Cytol 207: 113–150.
   PubMed Web of Science ®Google Scholar
• Crossen R, Gruenwald S (1997). Baculovirus Expression Vector System Manual, 4th ed., PharMingen, San Diego, CA, pp. 22–35.
   Google Scholar
• Czekay R-P, Aertgeerts K, Curriden SA, Loskutoff D (2003). Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins. J Cell Biol 160: 781–791.
   PubMed Web of Science ®Google Scholar
• Dalton A, McFarland CD, Underwood PA, Steele JG (1995). Role of the heparin binding domain of fibronectin in attachment and spreading of human bone derived cells. J Cell Sci 108: 2083–2092.
   PubMed Web of Science ®Google Scholar
• de Boer HC, Preissner KT, Bouma BN, de Groot PG (1992). Binding of vitronectin-thrombin-antithrombin III complex to human endothelial cells is mediated by the heparin binding site of vitronectin. J Biol Chem 267: 2264–2268.
   PubMedGoogle Scholar
• de Boer HC, Preissner KT, Bouma BN, de Groot PG (1995). Internalization of vitronectin-thrombin-antithrombin complex by endothelial cells leads to deposition of the complex into the subendothelial matrix. J Biol Chem 270: 30733–30740.
   PubMed Web of Science ®Google Scholar
• Delannet M, Martin F, Bossy B, Cheresh DA, Reichardt LF, Duband JL (1994). Specific roles of the ?v?1, ?v?3 and ?v?5 integrins in avian neural crest cell adhesion and migration on vitronectin. Development 120: 2687–2702.
   PubMed Web of Science ®Google Scholar
• Dufourcq P, Louis H, Moreau C, Daret D, Boisseau MR, Lamaziere JMD, Bonnet J (1998). Vitronectin expression and interaction with receptors in smooth muscle cells from human atheromatous plaque. Arterioscler Thromb Vasc Biol 18: 168–176.
   Google Scholar
• Echtermeyer F, Streit M, Wilcox-Adelman S, Saoncella S, Benhez F, Detmar M, Goetinck PF (2001). Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4. J Clin Invest 107: R9–R14.
   PubMed Web of Science ®Google Scholar
• Edens RE, LeBrun LA, Linhardt RJ, Kaul PR, Weiler JM (2001). Certain high molecular weight heparin chains have high affinity for vitronectin. Arch Biochem Biophys 391: 278–285.
   PubMed Web of Science ®Google Scholar
• Eitzman DT, Westrick RJ, Nabel EG, Ginsburg D (2000). Plasminogen activator inhibitor-1 and vitronectin promote vascular thrombosis in mice. Blood 95: 577–580.
   PubMed Web of Science ®Google Scholar
• Elenius K, Salmivitra M, Inki P, Mali M, Jalkanen M (1990). Binding of human syndecan to extracellular matrix proteins. J Biol Chem 265: 17837–17843.
   PubMed Web of Science ®Google Scholar
• Erdman R, Stahl RC, Rothblum K, Chernousov MA, Carey DJ (2002). Schwann cell adhesion to a novel heparan sulfate binding site in the N-terminal domain of the ?4 type V collagen is mediated by Syndecan-3. J Biol Chem 277: 7619–7625.
   PubMed Web of Science ®Google Scholar
• Francois PP, Preissner KT, Herrmann M, Haugland RP, Vaudaux P, Lew DP, Krause K-H (1999). Vitronectin interaction with glycosaminoglycans: Kinetics, structural determinants, and role in binding to endothelial cells. J Biol Chem 274: 37611–37619.
   PubMed Web of Science ®Google Scholar
• Gibson AD, Lamerdin JA, Zhuang P, Baburaj K, Serpersu EH, Peterson CB (1999). Orientation of heparin-binding sites in native vitronectin. J Biol Chem 274: 6432–6442.
   PubMedGoogle Scholar
• Gladson CL, Dennis C, Rotolo TC, Kelly DR, Grammer JR (1997). Vitronectin expression in differentiating neuroblastic tumors; Integrin ?v?5 mediates vitronectin-dependent adhesion of retinoic-acid-differentiated neuroblastoma cells. Am J Pathol 150: 1631–1646.
   PubMed Web of Science ®Google Scholar
• Gladson CL, Cheresh DA (1991). Glioblastoma expression of vitronectin and the ?v?3 integrin adhesion mechanism for transformed cells. J Clin Invest 88: 1924–1932.
   PubMed Web of Science ®Google Scholar
• Gladson CL, Wilcox JN, Sanders L, Gillespie GY, Cheresh DA (1995). Cerebral microenvironment influences expression of the vitronectin gene in astrocytic tumors. J Cell Sci 108: 947–956.
   PubMed Web of Science ®Google Scholar
• Godyna S, Liau G, Popa I, Stefansson S, Argraves WS (1995). Identification of the low density lipoprotein receptor-related protein (LRP) as an endocytic receptor for thrombospondin-1. J Cell Biol 129: 1403–1410.
   PubMed Web of Science ®Google Scholar
• Hageman GS, Mullins RF, Russell SR, Johnson LV, Anderson DH (1999). Vitronectin is a constituent of ocular drusen and the vitronectin gene is expressed in human retinal pigmented epithelial cells. FASEB J 13: 477–484.
   PubMed Web of Science ®Google Scholar
• Hocking DC, Sottile J, Reho T, Fassler R, McKeown-Longo PJ (1999). Inhibition of fibronectin matrix assembly by the heparinbinding domain of vitronectin. J Biol Chem 274: 27257–27264.
   PubMed Web of Science ®Google Scholar
• Horowitz A, Tkachenko E, SimonsM(2002). Fibroblast growth factor-specific modulation of cellular response by sydnecan-4. J Cell Biol 157: 715–725.
   Google Scholar
• Hortin GL, Schilling M, Graham JP (1988). Inhibitors of the sulfation of proteins, glycoproteins, and proteoglycans. Biochem Biophys Res Commun 150: 342–348.
   PubMed Web of Science ®Google Scholar
• Huang W, Chiquet-Ehrismann R, Moyano JV, Garcia-Pardo A, Orend G (2001). Interference of Tenascin-C with Syndecan-4 binding to fibronectin blocks cell adhesion and stimulates tumor cell proliferation. Cancer Res 61: 8586–8594.
   PubMed Web of Science ®Google Scholar
• Huebsch JC, McCarthy JB, Diglio CA, Mooradian DL (1995). Endothelial cell interactions with synthetic peptides from the carboxyl-terminal heparin-binding domains of fibronectin. Circ Res 77: 43–53.
   PubMed Web of Science ®Google Scholar
• Humphries DE, Silbert JE (1988). Chlorate: A reversible inhibitor of proteoglycan sulfation. Biochem Biophys Res Commun 154: 365–371.
   PubMed Web of Science ®Google Scholar
• Humphries DE, Sugumaran G, Silbert JE (1989). Decreasing sulfation of proteoglycans produced by cultured cells. Meth in Enzymol 179: 428–434.
   PubMed Web of Science ®Google Scholar
• Jang YC, Tsou R, Gibran NS, Isik FF (2000). Vitornectin deficiency is associated with increased wound fibrinolysis and decreased microvascular angiogenesis in mice. Surgery 127: 696–704.
   PubMed Web of Science ®Google Scholar
• Klass C, Couchman JR, Woods A (2000). Control of extracellular matrix assembly by syndecan-2-proteoglycan. J Cell Sci 113: 493–506.
   PubMed Web of Science ®Google Scholar
• Kost C, Stuber W, Ehrlich HJ, Pannekoek H, Preissner KT (1992). Mapping of binding sites for heparin, plasminogen activator inhibitor-1, and plasminogen to vitronectin’s heparinbinding region reveals a novel vitronectin-dependent feedback mechanism for the control of plasmin formation. J Biol Chem 267: 12098–12105.
   PubMed Web of Science ®Google Scholar
• Kumagai T, Lee I, Ono Y, Maeno M, Takagi M (1998). Ultrastructural localization and biochemical characterization of vitronectin in developing rat bone. Histochem J 30: 111–119.
   PubMedGoogle Scholar
• Kusano Y, Oguri K, Nagayasu Y, Munesue S, Ishihara M, Saiki I, Ynoekura H, Yamamoto H, OkayamaM(2000). Participation of Syndecan 2 in the induction of stress fiber formation in cooperation with integrin ?5?1: Structural characteristics of heparan sulfate chains with avidity to COOH-terminal heparin-binding domain of fibronectin. Exp Cell Res 256: 434–444.
   Google Scholar
• Langford JK, Stanley MJ, Cao D, Sanderson RD (1998). Multiple heparan sulfate chains are required for optimal Syndecan-1 function. J Biol Chem 273: 29965–29971.
   PubMed Web of Science ®Google Scholar
• Liang OD, Rosenblatt S, Chhatwal GS, Preissner KT (1997). Identification of novel heparin-binding domains of vitronectin. FEBS Lett. 407: 169–172.
   PubMed Web of Science ®Google Scholar
• LiebersbachBF, SandersonRD(1994). Expression of Syndecan- 1 inhibits cell invasion into Type I collagen. J Biol Chem 269: 20013–20019.
   Google Scholar
• Liu W, Litwack D, Stanley MJ, Langford JK, Lander AD, Sanderson RD (1998). Heparan sulfate proteoglycans as adhesive and anti-invasive molecules. J Biol Chem 273: 22825–22832.
   PubMed Web of Science ®Google Scholar
• Longley RL, Woods A Fleetwood A, Cowling GJ, Gallagher JT (1999). Control of morphology, cytoskeleton and migration by syndecan-4. J Cell Sci 112: 3421–3431.
   PubMed Web of Science ®Google Scholar
• Lyon M, Rushton G, Askari JA, Humphries MJ, Gallagher JT (2000). Elucidation of the structural features of heparan sulfate important for interaction with the Hep-2 domain of fibronectin. J Biol Chem 275: 4599–4606.
   PubMed Web of Science ®Google Scholar
• Martinez-Morales JR, Marti E, Frade JM, Rodriguez-Tebar A (1995). Developmentally regulated vitronectin influences cell differentiation, neuron survival and process outgrowth in the developing chicken retina. Neurosci 68: 245–253.
   PubMed Web of Science ®Google Scholar
• Memmo LM, McKeown-Longo P (1998). The ?v?5 integrin functions as an endocytic receptor for vitronectin. J Cell Sci 111: 425–433.
   PubMed Web of Science ®Google Scholar
• Mostafavi-Pour Z, Askari JA, Whittard JD, Humphries MJ (2001). Identification of a novel heparin-binding site in the alternatively spliced IIICS region of fibronectin: Roles of integrins and proteoglycans in cell adhesion to fibronectin splice variants. Matrix Biol 20: 63–63.
   PubMed Web of Science ®Google Scholar
• Noszczyk BH, Klein E, Holtkoetter O, Krieg T, Majewski S (2002). Integrin expression in the dermis during scar formation in humans. Exp Dermatol 11: 311–318.
   PubMed Web of Science ®Google Scholar
• Numa F, Hirabayashi K, Kawasaki K, Sakaguchi Y, Sugino N, Suehiro Y, Suminami Y, Hirakawa H, Umayahara K, Nawata S, Ogata H, Kato H (2002). Syndecan-1 expression in cancer of the uterine cervix: Association with lymph node metastasis. Int J Oncol 20: 39–43.
   PubMed Web of Science ®Google Scholar
• Odrljin TM, Francis CW, Sporn LA, Bunce LA, Marder VJ, Simpson-Haidaris PJ (1996). Heparin-binding domain of fibrin mediates its binding to endothelial cells. Arterioscler Thromb Vasc Biol 16: 1544–1551.
   PubMed Web of Science ®Google Scholar
• Oh E-S, Woods A, Couchman JR (1997). Multimerization of the cytoplasmic domain of syndecan-4 is required for its ability to activate protein kinase C. J Biol Chem 272: 11805–11811.
   PubMed Web of Science ®Google Scholar
• Oh E-S, Woods A, Couchman JR (1997). Syndecan-4 proteoglycan regulates the distribution and activity of protein kinase C. J Biol Chem 272: 8133–8136.
   PubMed Web of Science ®Google Scholar
• Oliver N, Newby RF, Furcht LT, Bourgeois S (1983). Regulation of fibronectin biosynthesis by glucocorticoids in human fibrosarcoma cells and normal fibroblasts. Cell 33: 287–296.
   PubMed Web of Science ®Google Scholar
• Ozaki S, Johnson LV, Mullins RF, Hageman GS, Anderson DH (1999). The human retina and retinal pigment epithelium are abundant sources of vitronectin mRNA. Biochem Biophys Res Comm 258: 524–529.
   PubMed Web of Science ®Google Scholar
• Panetti TS, McKeown-Longo PJ (1993). Receptor mediated endocytosis of vitronectin is regulated by its conformational state. J Biol Chem 268: 11988–11993.
   PubMed Web of Science ®Google Scholar
• Panetti TS, McKeown-Longo PJ (1993). The ?v?5 integrin receptor regulates receptor-mediated endocytosis of vitronectin. J Biol Chem 268: 11492–11495.
   PubMed Web of Science ®Google Scholar
• Panetti TS, Wilcox SA, Horzempa C, McKeown-Longo PJ (1995). ?v?5 integrin receptor-mediated endocytosis of vitronectin is protein kinase C-dependent. J Biol Chem 270: 18593–18597.
   PubMed Web of Science ®Google Scholar
• Pijuan-Thompson V, Gladson CL (1997). Ligation of integrin ?5?1 is required for internalization of vitronectin by integrin ?v?3. J Biol Chem 272: 2736–2743.
   PubMed Web of Science ®Google Scholar
• Preissner KT, Seiffert D (1998). Role of vitronectin and its receptors in haemostasis and vascular remodeling. Thromb Res 89: 1–21.
   PubMed Web of Science ®Google Scholar
• Preissner KT, Muller-Berghaus G (1986). S-protein modulates the heparin-catalyzed inhibition of thrombin by antithrombin III. Eur J Biochem 156: 645–650.
   PubMedGoogle Scholar
• Preissner KT, Muller-Berghaus G (1987). Neutralization and binding of heparin by S-protein/vitronectin in the inhibition of factor Xa by anti-thrombin III. J Biol Chem 262: 12247–12253.
   PubMed Web of Science ®Google Scholar
• Rapraeger AC, Ott VL (1998). Molecular interactions of the syndecan core proteins. Curr Opin Cell Biol 10: 620–628.
   PubMed Web of Science ®Google Scholar
• Sanderson RD, Borset M (2002). Syndecan-1 in B lymphoid malignancies. Ann Hematol 81: 125–135.
   PubMed Web of Science ®Google Scholar
• Sanderson RD, Turnbull JE, Gallagher JT, Lander AD (1994). Fine structure of heparan sulfate regulates syndecan-1 function and cell behavior. J Biol Chem 269: 13100–13106.
   PubMed Web of Science ®Google Scholar
• Saoncella S, Echtermeyer F, Denhez F, Nowlen J, Mosher DF (1999). Syndecan-4 signals cooperatively with integrins in a Rho-dependent manner in the assembly of focal adhesions and actin stress fibers. Proc Natl Acad Sci 96: 2805–2810.
   PubMed Web of Science ®Google Scholar
• Scaffidi AK, Moodley YP, Weichselbaum M, Thompson PJ, Knight DA (2001). Regulation of human lung fibroblast phenotype and function by vitronectin and vitronectin integrins. J Cell Sci 114: 3507–3516.
   PubMed Web of Science ®Google Scholar
• Seiffert D (1997). The glycosaminoglycan binding site governs ligand binding to the somatomedin ? domain of vitronectin. J Biol Chem 272: 9971–9978.
   PubMed Web of Science ®Google Scholar
• Seiffert D, Iruela-Arispe ML, Sage EH, Loskutoff DJ (1995). Distribution of vitronectin mRNA during murine development. Develop Dynamics 203: 71–79.
   PubMed Web of Science ®Google Scholar
• Seiffert D, Keeton M, Eguchi Y, Sawdey M, Loskutoiff DJ (1991). Detection of vitronectin mRNA in tissues and cells of the mouse. Proc Natl Acad Sci USA 88: 9402–9406.
   PubMed Web of Science ®Google Scholar
• Seiffert D, SmithJW(1997). The cell adhesion domain in plasma vitronectin is cryptic. J Biol Chem 272: 13705–13710.
   Google Scholar
• Shaltiel S, Schvartz I, Korc-Grodzicki B, Kreizman T (1993). Evidence for an extra-cellular function for protein kinase A. Molec Cell Biochem 127/128: 283–291.
   Google Scholar
• Sobel M, Soler DF, Kermode JC, Harris RB (1992). Localization and characterization of a heparin binding domain peptide of human von Willebrand factor. J Biol Chem 267: 8857–8862.
   PubMed Web of Science ®Google Scholar
• Stepp MA, Gibson HE, Gala PH, Iglesia DD, Pajoohesh-Ganji A, Pal-Ghosh S, Brown M, Aquino C, Schwartz AM, Goldberger O, Hinkes MT, BernfieldM(2002). Defects in keratinocyte activation during wound healing in the syndecan-1 deficient mouse. J Cell Sci 115: 4517–4531.
   Google Scholar
• Suzuki S, Pierschbacher MD, Hayman EG, Nguyen K, Ohgren Y, Ruoslahti E (1984). Domain structure of vitronectin. J Biol Chem 259: 15307–15314.
   PubMed Web of Science ®Google Scholar
• Tomasini BR, Mosher DF (1990). Vitronectin. Prog Hemostasis Thromb 10: 269–305.
   Google Scholar
• Tomasini-Johansson BR, Milbrink J, Pejler G (1998). Vitronectin expression in rheumatoid arthritic synovia-Inhibition of plasmin generation by vitronectin produced in vitro. Brit J Rheumatol 37: 620–629.
   PubMedGoogle Scholar
• Tomasini-Johansson NR, Sundberg C, Lindmark G, Gailit JO, Rubin K (1994). Vitronectin in colorectal adenocarcinoma- Synthesis by stromal cells in culture. Exp Cell Res 214: 303–312.
   PubMed Web of Science ®Google Scholar
• Uchiyama H, Barut BA, Chauhan D, Cannistra SA, Anderson KC (1992). Characterization of adhesion molecules on human myeloma cell lines. Blood 80: 2306–2314.
   PubMed Web of Science ®Google Scholar
• Utani A, Nomizi M, Matsuura H, Kato K, Kobayashi T, Takeda U, Aota S, Nielsen PK, Shinkai H (2001). A unique sequence of the laminin ?3 g domain binds to heparin and promotes cell adhesion through Syndecan-2 and -4. J Biol Chem 276: 28779–29788.
   PubMed Web of Science ®Google Scholar
• vanAken BE, SeiffertD, Thinnes T, LoskutoffDJ (1997). Localization of vitronectin in the normal and atherosclerotic human vessel wall. Histochem Cell Biol 107: 313–320.
   PubMed Web of Science ®Google Scholar
• Vogel BE, Lee S-J, Hildebrand A, Craig W, Pierschbacher MD, Wong-Staal F, Ruoslahti E (1993). A novel integrin specificity exemplified by binding of the ?v?5 integrin to the basic domain of the HIV Tat protein and vitronectin. J Cell Biol 121: 461–468.
   PubMed Web of Science ®Google Scholar
• Wells MJ, Blajchman MA (1998). In vivo clearance of ternary complexes of vitronectin-thrombin-antithrombin is mediated by hepatic heparan sulfate proteoglycans. J Biol Chem 273: 23440–23447.
   PubMed Web of Science ®Google Scholar
• Wilcox-Adelman SA, Wilkins-Port CE, McKeown-Longo PJ (2000). Localization of urokinase type plasminogen activator to focal adhesions requires ligation of vitronectin integrin receptors. Cell Adhes Commun 7: 477–490.
   PubMed Web of Science ®Google Scholar
• Wilkins-Port CE, McKeown-Longo PJ (1998). Degradation of distinct forms of multimeric vitronectin by human fibroblasts. Biochim et Biophys Acta 1404: 353–366.
   PubMed Web of Science ®Google Scholar
• Wilkins-Port CE, McKeown-Longo P (1996). Heparan sulfate proteoglycans function in the binding and degradation of vitronectin by fibroblast monolayers. Biochem Cell Biol 74: 887–897.
   PubMed Web of Science ®Google Scholar
• Woods A (2001). Syndecans: Transmembrane modulators of adhesion and matrix assembly. J Clin Invest 107: 935–941.
   PubMed Web of Science ®Google Scholar
• Woods A, Longley RL, Tumova S, Couchman JR (2000). Syndecan-4 binding to the high affinity heparin-binding domain of fibronectin drives focal adhesion. Formation in fibroblasts. Arch Biochem Biophys 374: 66–72.
   PubMed Web of Science ®Google Scholar
• Worapamorn W, Xiao Y, Li H, Young WG, Bartold PM (2002). Differential expression and distribution of syndecan-1 and -2 in periodontal wound healing of the rat. J Peridontal Res 37: 293–299.
   PubMed Web of Science ®Google Scholar
• Yatohgo T, Izumi M, Kashiwagi H, Hayashi M (1988). Novel purification of vitronectin from human plasma by heparin affinity chromatography. Cell Struct Funct 13: 281–292.
   PubMed Web of Science ®Google Scholar
• Yoneda A, Ogawa H, Kojima K, Matsumoto I (1998). Characterization of the ligand binding activities of vitronectin: Interaction of vitronectin with lipids and identification of the binding domains for various ligands using recombinant domains. Biochemistry 37: 6351–6360.
   PubMed Web of Science ®Google Scholar
• Zellweger T, Ninck C, Mirlacher M, Annefeld M, Glass AG, Gasser TC, Mihatsch JJ, Gelmann EP, Bubendorf L (2003). Tissue microarray analysis reveals prognostic significance of syndecan-1 expression in prostate cancer. Prostate 55: 20–29.
   PubMed Web of Science ®Google Scholar
• Zhang G, Kim H, Cai X, Lopez-Guisa JM, Carmeliet P, EddyAA (2003). Urokinase receptor modulates cellular and angiogenic responses in obstructure nephropathy. J Am Soc Nephrol 14: 1234–1253.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Sane DC (1993). The cell attachment and spreading activity of vitronectin is dependent on the arg-gly-asp sequence; analysis by construction of RGD and domain deletion mutants. Biochem Biophys Res Comm 192: 575–582.
   PubMed Web of Science ®Google Scholar
• Zimmerman P, David G (1999). The syndecans, tuners of transmembrane signaling. FASEB J 13: S91–S100.
   PubMed Web of Science ®Google Scholar